Bladder Cancer Think Tank

Bladder cancer is the sixth most common cancer in the United States with over 81,000 new cases and more than 17,000 deaths projected for 2018. With only recent advances in treatments over the past 30 years, there continues to be a tremendous need for more bladder cancer research. Through our annual Bladder Cancer Think Tank Meeting, BCAN has created an essential vehicle for advancing collaborative research efforts in bladder cancer. This scientific retreat is the premier annual bladder cancer-specific medical meeting in North America. Since its inception in 2006, the Think Tank meeting has focused on identifying obstacles and creating solutions in bladder cancer research, and has fostered discussions to help define priorities for advancing bladder cancer research. Invited participants include urologists, oncologists, researchers, pathologists, social scientists, patient advocates and industry representatives, all who are dedicated to improving the diagnosis and treatment of bladder cancer.